Treating Blood Cancers

By: The Leukemia & Lymphoma Society
Listen for free

  • Summary

  • LLS Podcast Series for Professionals
    2019 Treating Blood Cancers Podcast Series - The Leukemia & Lymphoma Society
    Show More Show Less
Hygiene & Healthy Living Nature & Ecology Physical Illness & Disease
Show More Show Less
Episodes
  • Exploring Cutaneous T-Cell Lymphoma

    Exploring Cutaneous T-Cell Lymphoma
    Jan 31 2025
    Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL Recorded on January 7, 2025 Jaehyuk (Jae) Choi, MD Jack W. Graffin Associate Professor of Dermatology and of Biochemistry and Molecular Genetics Northwestern University Feinberg School of Medicine Chicago, IL In this episode, Dr. Jaehyuk Choi from Northwestern University, explores Cutaneous T-Cell Lymphoma (CTCL), covering key diagnostic tools, emerging therapies, and the importance of a multidisciplinary team approach. He delves into effective symptom management, including the psychosocial impact of pruritus, and discusses the latest ongoing research. Additionally, Dr. Choi highlights disparities in diagnosis, treatment access, and patient outcomes. Tune in today to gain valuable insights on this complex diagnosis! This episode is supported by Kyowa Kirin, Inc.
    Show More Show Less
    32 mins
  • Highlights from Attending ASH 2024

    Highlights from Attending ASH 2024
    Jan 17 2025
    Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2024 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide information presented at the 66th American Society of Hematology (ASH) Annual Meeting, including updates in myeloma, leukemia, and lymphoma. Dr. Greenberger also discusses updates in blood cancer therapies, including nutrition, CAR T-cell therapy, and bispecifics. Tune in today! This episode is supported by Autolus Therapeutics.
    Show More Show Less
    51 mins
  • Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

    Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma
    Dec 19 2024
    Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL Recorded on November 21, 2024 Celeste Bello, MD Senior Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more!
    Show More Show Less
    26 mins

What listeners say about Treating Blood Cancers

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available